On (b)(6) 2009, (b)(6) chief of spine services and medtronic consultant dr (b)(6) performed l4-5, l5-s1 two-level lumbar fusion with large ii infuse bone graft in combination with two integra hollywood nanometalene interbody cage spacers and synthes/universal instrumentation (rods, screws, connectors).Seaspine and stryker sales reps were in attendance during operative procedure.Pt developed post-operative complications that health care providers failed to disclose were attributed to known complications associated with improper dosage/preparation of rhbmp-2/acs sponge components of the combination product used in indications not cleared by the fda, including but not limited to permanent posterior bone resorption at l4-s1 and heterotopic bone growth that escaped out of the cages at both levels around the dura and the transversing nerve root.Pt requires revision surgery decompression and removal of heterotopic bone growth at both levels.On information and belief the infuse bone graft combination product pma 000058 was adulterated and misbranded "when it the lt-cage component was unbundled and rebundled with the integra hollywood nanometalene interbody cage." not fda cleared to be introduced into interstate commerce until may 2011 under k102026.
|